Leading the development of endovascular aortic repair, Medtronic, Inc.
MDT today announced the start of its U.S. post-approval study of the
Endurant AAA Stent Graft System, a medical device used to treat abdominal
aortic aneurysms.
MDTMedtronic PLC
$92.74-0.57%
Edge Rankings
Momentum72.25
Growth62.61
Quality44.05
Value20.78
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in